Abstract
Prochloraz is an imidazole fungicide, and its regulatory toxicological data package has been primarily generated in the 1990s. More recently, studies have been published demonstrating an interaction with hormone receptors/steroidogenesis and effects with an endocrine mode of action. In the present study, prochloraz has been investigated in a comprehensive in vivo study including relevant elements of current regulatory reproduction toxicity studies and additional mechanistic parameters. Prochloraz was administered per gavage in oil from GD 6 to PND 83 to pregnant and lactating Wistar rats and their respective offspring, at doses of 0.01 mg/kg bw/day (acceptable daily intake of prochloraz), 5 mg/kg bw/day [expected no-observed-effect-level (NOEL)] and 30 mg/kg bw/day. At 30 mg/kg bw/day maternal and offspring effects (decreased viability, lower number of live offspring) were seen including a delayed entry into male puberty (+1 day) accompanied by lower male offspring body weights, increased anogenital distance/index in females and transiently retained nipples in males at PND 12 (not seen at PND 20). The only finding at the “expected NOEL” was increased incidences of transiently retained nipples in males which are not considered adverse. No effects were seen in the low-dose group. There was no evidence for a non-monotonic dose–response curve or effects at low levels.
Similar content being viewed by others
References
Andersen HR, Vinggaard AM, Rasmussen TH, Gjermandsen IM, Bonefeld-Jorgensen EC (2002) Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol 179:1–12
Bars R, Fegert I, Gross M, Lewis D, Weltje L, Weyers A, Wheeler JR, Galay-Burgos M (2012) Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern. Regul Toxicol Pharmacol 64:143–154
Birkhoj M, Nellemann C, Jarfelt K, Jacobsen H, Andersen HR, Dalgaard M, Vinggaard AM (2004) The combined anti-androgenic effects of five commonly used pesticides. Toxicol Appl Pharmacol 201(1):10–20
Blystone CR, Furr J, Lambright CS, Howdeshell KL, Ryan BC, Wilson VS, LeBlanc GA, Gray LE (2007a) Prochloraz inhibits testosterone production at dosages below those that affect androgen-dependent organ weights or the onset of puberty in the male Sprague Dawley rat. Toxicol Sci 97(1):65–74
Blystone CR, Lambritth CS, Howdeshell KL, Furr J, Sternberg RM, Butterworth BC, Durhan EJ, Makynen EA, Ankley GT, Wilson VS, LeBlanc GA, Gray LE (2007b) Sensitivity of fetal rat testicular steroidogenesis to maternal prochloraz exposure and the underlying mechanism of inhibition. Toxicol Sci 97(2):512–519
Borgert CJ, Sargent EV, Casella G, Dietrich DR, McCarty LS, Golden RJ (2012) the human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments. Regul Toxicol Pharmacol 62:313–328
Borgert CJ, Baker SP, Matthews JC (2013) Potency matters, thresholds govern endocrine activity. Regul Toxicol Pharmacol 67(1):83–88
Caldwell DJ, Mastrocco F, Anderson PD, Länge R, Sumpter JP (2012) Predicted-no-effect concentrations for the steroid estrogens estrone, 17β-estradiol, estriol and 17α-ethinylestradiol. Environ Toxicol Chem 31:1396–1406
Carney EW, Zablotny CL, Marty MS, Crissman JW, Anderson P, Woolhiser M, Holsapple M (2004) The effects of feed restriction during in utero and postnatal development in rats. Toxicol Sci 82:237–249
Chernoff N, Gage MJ, Stoker TE, Cooper RL, Gilbert ME, Rogers EH (2009) Reproductive effects of maternal and pre-weaning undernutrition in rat offspring: age at puberty, onset of female reproductive senescence and intergenerational pup growth and viability. Reprod Toxicol 28:489–494
Christiansen S, Scholze M, Dalgaard M, Vinggaard AM, Axelstad M, Kortenkamp A, Hass U (2009) Synergistic disruption of external male sex organ development by a mixture of four anti-androgens. Environ Health Perspect 117:1839–1846
Commission Regulation (EU) No. 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market
Dekant W, Colnot T (2013) Endocrine effects of chemicals: aspects of hazard identification and human health risk assessment. Toxicol Lett 223(3):280–286
DeSesso JM, Scialli AR, White TEK, Breckenridge CB (2014) Multigeneration reproduction and male developmental toxicity studies on atrazine in rats. Birth Defects Res B Dev Reprod Toxicol 101(3):237–253
EC 1107/2009 Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC
EFSA (2009) Scientific Opinion on Risk Assessment for a selected group of pesticides from the triazole group to test possible methodologies to assess cumulative effects from exposure through food from these pesticides on human health. EFSA J 7(9):1167
EFSA (2011) Conclusion on the peer review of the pesticide risk assessment of the active substance prochloraz. EFSA J 9(7):2323
EFSA (2013) Scientific Opinion on the hazard assessment of endocrine disruptors: scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. EFSA J 11(3):3132
EFSA—Rapporteur member State assessment reports submitted for the EU peer review of active substances used in plant protection products. http://dar.efsa.europe.eu/dar-web/provision
Fang X, Wong S, Mitchell BF (1996) Relationships among sex steroid, oxytocin, and their receptors in the rat uterus during late gestation and at parturition. Endocrinology 137(8):3213–3219
Fussell KC, Schneider S, Buesen R, Groeters S, Strauss V, Melching-Kollmuss S, van Ravenzwaay B (2015) Investigations of putative reproductive toxicity of low-dose exposures to flutamide in Wistar rats. Arch Toxicol 89:2385–2402
Grünfeld HT, Bonefeld-Jorgensen EC (2004) Effect of in vitro estrogenic pesticides on human oestrogen receptor α and β mRNA levels. Toxicol Lett 151:467–480
Haluska GJ, Cook MJ, Novy MJ (1997) Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys. Am J Obstet Gynecol 176:682–691
Hass U, Christiansen S, Axelstad M, Sorensen KD, Boberg J (2013) Input for the REACH-review in 2013 on endocrine disruptors. Final Rep 21:1–50
Hecker M, Newsted JL, Murphy MB, Higley EB, Jones PD, Wu R, Giesy JP (2006) Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: hormone production. Toxicol Appl Pharmacol 217:114–124
ICH Harmonised Tripartite Guideline Detection of toxicity to reproduction for medicinal products & toxicity to male fertility S5(R2); 4.1.2 Study for effects on pre- and postnatal developmental, including maternal function, parent guideline dated 24 June 1993; addendum dated 9 November 2000 incorporated in November 2005; can be downloaded from the internet. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S5/Step4/S5_R2__Guideline.pdf
Kemi (2013) Is it possible to determine thresholds for the effects of endocrine disruptors? A summary of scientific argumentation from 15 relevant publications on endocrine disruption. http://www.kemi.se/Documents/Publikationer/Trycksaker/PM/PM2-13.pdf
Kojima H, Katsura E, Takeuchi S, Niiyama K, Kobayashi K (2004) Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environ Health Perspect 112:524–531
Korenbrot CC, Huhtaniemi IT, Weiner RI (1977) Preputial separation as an external sign of pubertal development in male rat. Biol Reprod 17:298–303
Kortenkamp A, Martin O, Faust M, Evans R, McKinlay R, Orton F, Rosivatz E (2011) State of the art assessment of endocrine disrupters. Final Report; Project Contract Number 070307/2009/550687/SER/D3; 23.12.2011 (online available)
Laier P, Metzdorff SB, Borch J, Hagen ML, Hass U, Christiansen S, Axelstad M, Kledal T, Dalgaard M, McKinnell C, Brokken LJS, Vinggaard AM (2006) Mechanisms of action underlying the antiandrogenic effects of the fungicide prochloraz. Toxicol Appl Pharamcol 213:160–171
Lamb JC, Boffetta P, Foster WG, Goodman JE, Hentz KL, Rhomberg LR, Stavely J, Swaen G, Van der Kraak G, Williams AL (2014) Critical comments on the WHO–UNEP state of the science of endocrine disrupting chemicals—2012. Regul Toxicol Pharmacol 69:22–40
Marty MS, Johnson KA, Carney EW (2003) Effect of feed restriction on Hershberger and pubertal male assay endpoints. Birth Defects Res B Dev Reprod Toxicol 68:363–374
Marx-Stoelting P, Pfeil R, Solecki R, Ulbrich B, Grote K, Ritz V, Banasiak U, Heinrich-Hirsch B, Moeller T, Chahoud I, Hirsch-Ernst KI (2011) Assessment strategies and decision criteria for pesticides with endocrine disrupting properties relevant to humans. Reprod Toxicol 31:574–584
Marx-Stoelting P, Niemann L, Ritz V, Ulbrich B, Gall A, Hirsch-Ernst KI, Pfeil R, Solecki R (2014) Assessment of three approaches for regulatory decision making on pesticides with endocrine disrupting properties. Regul Toxicol Pharmacol 70(3):560–604, and Corrigendum to “Assessment of three approaches for regulatory decision making on pesticides with endocrine disrupting properties”. Regul Toxicol Pharmacol 72:256
Melching-Kollmuss S, Fussell KC, Buesen R, Dammann M, Schneider S, Tennekes H, van Ravenzwaay B (2014) Anti-androgenicity can only be evaluated using a weight of evidence approach. Regul Toxicol Pharmacol 68:175–192
Mitchell BF, Taggart MJ (2009) Are animal model relevant to key aspects of human parturition? Am J Physiol Regul Integr Comp Physiol 297:R525–R545
Nielsen FK, Hansen CH, Fey JA, Hansen M, Jacobsen NW, Halling-Sorensen B, Björklund E, Styrishave B (2012) H295R cells as a model for steroidogenic disruption: a broader perspective using simultaneous chemical analysis of 7 key steroid hormones. Toxicol In Vitro 26:343–350
Noriega NC, Ostby J, Lambright C, Wilson VS, Gray LE (2005) Late gestational exposure to the fungicide prochloraz delays the onset of parturition and causes reproductive malformations in male but not female rat offspring. Biol Reprod 72:1324–1335
OECD TG 456 H295R Steroidogenesis Assay, adopted 28 July 2011
OECD Conceptual Framework (2002). http://www.oecd.org/document/58/0,3343,en_2649_34377_2348794_1_1_1_1,00.html
OECD 2012 Guidance document (GD) on standardized test guidelines for evaluating chemicals for endocrine disruption: Case studies using example chemicals. Series on testing and assessment, No. 181, ENV/JM/MONO(2012)34, 08 October 2012
OECD TG 414 Prenatal developmental toxicity study, adopted 22 January 2001
OECD TG 416 Two-Generation Reproduction Toxicity Study; adopted 22 January 2001
OECD TG 416 Two-Generation Reproduction Toxicity Study; adopted 26 May 1983
OECD TG 443 Extended One-Generation Reproductive Toxicity Study, adopted 28 July 2011
OECD TG 414 Teratogenicity, adopted 12 May 1981
Ohlsson A, Ulleras E, Oskarsson A (2009) A biphasic effect of the fungicide prochloraz on aldosterone, but not cortisol, secretion in human adrenal H295R cells—underlying mechanism. Toxicol Lett 191:174–180
Ohlsson A, Cedergreen N, Oskarsson A, Ulleras E (2010) Mixture effects of imidazole fungicides on cortisol and aldosterone secretion in human adrenocortical H295R cells. Toxicology 275:21–28
Rhomberg LR, Goodman JE (2012) Low-dose effects and nonmonotonic dose–responses of endocrine disrupting chemicals: has the case been made? Regul Toxicol Pharmacol 64(1):130–133
Salewski E (1964) Färbemethode Zum makroskopischen Nachweis von Implanatationsstellen am Uterus der Ratte. Naunyn-Schmiedebergs Archiv für experimentelle Pathology und Pharmakologie 247:367
Sanderson JT, Boerma J, Lansbergen GWA, van den Berg M (2002) Induction and inhibition of aromatase (Cyp19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicol Appl Pharmacol 182:44–54
Trösken ER, Scholz K, Lutz RW, Völkel W, Zarn JA, Lutz WK (2004) Comparative assessment of the inhibition of recombinant human Cyp19 (Aromatase) by azoles used in agriculture and as drugs for humans. Endocr Res 30(3):387–394
US Congress and US Environmental Protection Agency (1972) US Federal Insecticide, Fungicide and Rodenticide Act (FIFRA): good laboratory practice standards. 40 code of federal regulations part 160
US Congress and US Environmental Protection Agency (1976) US Toxic Substances Control Act (TSCA): good laboratory practice standards. 40 code of federal regulations part 792
UNEP and WHO (2013) State of the science of endocrine disrupting chemicals—2012
US-EPA Health Effects Test Guidelines OPPTS 870.3800 Reproduction and Fertility Effects, August 1998
US-EPA Health Effects Test Guidelines OPPTS 870.3700 Prenatal Developmental Toxicity Study, August 1998
US EPA EDSP Endocrine Disruptor Screening Program. http://www.epa.gov/endo/
Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee D-H, Shioda T, Soto AM, vom Saal FS (2012) Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33(3):378–455
Vinggaard AM, Hnida C, Breinholt V, Larsen JC (2000) Screening of selected pesticides for inhibition of Cyp19 aromatase activity in vitro. Toxicol In Vitro 14:227–234
Vinggaard AM, Nellemann C, Dalgaard M, Jorgensen EB, Andersen HR (2002) Antiaandrogenic effects in vitro and in vivo of the fungicide prochloraz. Toxicol Sci 69:344–353
Vinggaard AM, Christiansen S, Laier P, Poulsen ME, Breinholt V, Jarfelt K, Jacobsen H, Dalgaard M, Nellemann C, Hass U (2005) perinatal exposure to the fungicide prochloraz feminizes the male rat offspring. Toxicol Sci 85:886–897
Winther CS, Nielsen FK, Hansen M, Styrishave B (2013) Corticosteroid production in H295R cells during exposure to 3 endocrine disrupters analyzed with LC-MS/MS. Int J Toxicol 32(3):219–227
Woodman DD (1997) Laboratory Animal Endocrinology: hormonal action, control mechanisms and interactions with drugs. Wiley, Chichester, p 458. ISBN 978-0-471-97262-4
Yamada H, Yamahara A, Yasuda S, Abe M, Oguri K, Fukushima S, Ikeda-Wada S (2002) Dansyl chloride derivatization of methamphetamine: a method with advantages for screening and analysis of methamphetamine in urine. J Anal Toxicol 26:17–22
Zakar T, Hertelendy F (2007) Progesterone withdrawal: key to parturition. Am J Obstet Gynecol 196(4):289–296
Zhang F, Rick DL, Kann LH, Perala AW, Geter DR, LeBaron MJ, Bartels MJ (2011) Simultaneous quantitation of testosterone and estradiol in human cell line (H295R) by liquid chromatography/positive atmospheric pressure photoionization tandem mass spectrometry. Rapid Commun Mass Spectrom 25(20):3123–3130
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Melching-Kollmuss, S., Fussell, K.C., Schneider, S. et al. Comparing effect levels of regulatory studies with endpoints derived in targeted anti-androgenic studies: example prochloraz. Arch Toxicol 91, 143–162 (2017). https://doi.org/10.1007/s00204-016-1678-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-016-1678-y